Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study
Authors:
Open Access
- 1 June 2013
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 147 (1) , 95-102
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The concepts of remission and recovery in schizophreniaCurrent Opinion in Psychiatry, 2011
- Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophreniaClinicoEconomics and Outcomes Research, 2011
- The cost of relapse and the predictors of relapse in the treatment of schizophreniaBMC Psychiatry, 2010
- Influence of antipsychotics on mortality in schizophrenia: Systematic reviewSchizophrenia Research, 2009
- Lurasidone in the Treatment of Acute SchizophreniaThe Journal of Clinical Psychiatry, 2009
- Testing Definitions of Symptom Remission in First-Episode Psychosis for Prediction of Functional Outcome at 2 YearsSchizophrenia Bulletin, 2009
- A Systematic Review of Mortality in SchizophreniaArchives of General Psychiatry, 2007
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970